niacinamide and Drug Hypersensitivity
niacinamide has been researched along with Drug Hypersensitivity in 3 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Drug Hypersensitivity: Immunologically mediated adverse reactions to medicinal substances used legally or illegally.
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Linauskiene, K | 1 |
Malinauskiene, L | 1 |
Vitkauskaite, E | 1 |
Chomiciene, A | 1 |
Blaziene, A | 1 |
Simonelli, M | 1 |
Zucali, PA | 1 |
Lorenzi, E | 1 |
Rubino, L | 1 |
De Vincenzo, F | 1 |
De Sanctis, R | 1 |
Perrino, M | 1 |
Mancini, L | 1 |
Di Tommaso, L | 1 |
Rimassa, L | 1 |
Masci, G | 1 |
Zuradelli, M | 1 |
Suter, MB | 1 |
Bertossi, M | 1 |
Fattuzzo, G | 1 |
Giordano, L | 1 |
Roncalli, MG | 1 |
Santoro, A | 1 |
Dotsenkov, VA | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Phase I and Pharmacokinetics Study of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid Tumors[NCT00984425] | Phase 1 | 30 participants (Actual) | Interventional | 2009-09-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trials
1 trial available for niacinamide and Drug Hypersensitivity
Article | Year |
---|---|
Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Dose-Response Rela | 2013 |
Other Studies
2 other studies available for niacinamide and Drug Hypersensitivity
Article | Year |
---|---|
Severe adverse skin reaction and desensitization to sorafenib.
Topics: Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Growth Processes; Desensitization, Imm | 2016 |
[Indices of the vitamin C, P, B1, B6 and PP allowances in experimental chromium sensitization].
Topics: Animals; Ascorbic Acid; Chromium; Dose-Response Relationship, Immunologic; Drug Hypersensitivity; Fl | 1978 |